Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.
Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S.
Yamada T, et al. Among authors: takeuchi s.
Oncogene. 2013 Sep 12;32(37):4427-35. doi: 10.1038/onc.2012.446. Epub 2012 Oct 8.
Oncogene. 2013.
PMID: 23045273